2023 ACMG Annual Clinical Genetics Meeting Digital Edition

(32)

Availability

On-Demand

2 Courses

Expires on Mar 31, 2025

Cost

ACMG Member: $599.00

Non-Member: $749.00

Postdoc/Trainee (M): $199.00

Postdoc/Trainee (NM): $249.00

Student (M): $199.00

Student (NM): $249.00

Credit Offered

46.5 CME (AMA) Credits

46.5 CME (Other) Credits

46.5 P.A.C.E. Credits

46.5 NSGC Credits

First time Users
Course Information
Accredited Sessions
ACMG Accredited Continuing Education Information
Financial Disclosures

First time users: You will need to check your degree as you created an ACMG account. The system designates educational credits according to your degree. Be sure you are logged in (do you see your name on the top right under the ACMG Genetics Academy logo?). If not, log in before proceeding.

For technical support, please send an email to: education@acmg.net or call 301-718-9603.

Or click on the "Help" icon on the left-hand side of your screen for more information.

Support Center Hours: Monday- Friday 9:00 am - 5:00 pm Eastern Time

Date of Release: April 17, 2023

Expiration Date: March 31, 2025

Credits offered: CME, P.A.C.E.®, NSGC

Estimate time of completion: 46.5 hours

NSGC credit reports are sent annually (see reporting timeline below).

COURSE DESCRIPTION

The 2023 Annual Clinical Genetics Meeting Digital Edition will present both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions will focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory's role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.

Learning Objectives

At the conclusion of this course, participants should be able to:

Describe the advances in genetic testing including prenatal and postnatal indications, gene panels, genome sequencing, interpretation, genetic counseling, and ethical and legal issues.
Review select rare and common genetic disorders, from developmental disabilities to cancer predisposition syndromes, as well as novel therapeutic approaches including gene editing.
Review select inborn errors of metabolism, approaches to their diagnoses and treatment, new disorders on the recommended uniform screening panel.
Recognize the importance of diversity, equity, and Inclusion in genetic clinical care and research, and inclusion as an essential component for genetic workforce development.
Analyze the need for innovation and new approaches to transforming the current practice of genetic medicine to achieve a vision of genomically-informed precision population health.

Target Audience

All healthcare professionals interested in the diagnosis, management, treatment, and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. The ACMG Annual Meeting is targeted for the following professionals:

Medical and clinical geneticists; genetic counselors; pediatric, obstetric, and maternal-fetal specialists; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, genetically influenced health problems
Laboratory directors and technicians who conduct genetic testing
Researchers involved in the discovery of genetic disorders and treatments
Clinical, laboratory and research trainees of genetics and all biomedical sciences
Any healthcare and public health professionals who have an in interest in medical and clinical genetics and genomics
Advocates for patients with genetic conditions and their families

Session Topic	Session (Titles may be abbreviated)	CME/ NSGC/ P.A.C.E.®
Biochemical/Metabolic and Therapeutics	NAMA 2.0. Inborn Errors of Complex Molecule Metabolism: What’s Hiding in Your General Genetics Clinic?	1.5
Biochemical/Metabolic and Therapeutics	That’s Metabolic Now?!? (ACMG/SIMD Joint Session)	1.5
Biochemical/Metabolic and Therapeutics	Inborn Errors of Metabolism (IEM) Presenting in Specialty Clinics: Educating Providers to Identify Treatable IEMs	1.5
Biochemical/Metabolic and Therapeutics	My NGS Panel is Positive for What? When Metabolic Disorders Are Identified on NGS Panels (ACMG/SIMD Joint Session)	1.5
Cancer Genetics and Therapeutics	Inherited Cancer Care: Overview of National Resources and Synergies	1.5
Cancer Genetics and Therapeutics	Paraganglioma Pheochromocytoma Syndrome (PGL/PCC): Genetics, Management, and Basic Science	1.5
Cancer Genetics and Therapeutics	Innovations in the Delivery of Cancer Genetic Services to Medically Underserved Populations	1.5
Clinical Genetics and Therapeutics	Polygenic Risk Score, Clinical Use and Limitations, Where Do We Stand?	1.5
Clinical Genetics and Therapeutics	Updates in Inborn Error of Immunity	1.5
Clinical Genetics and Therapeutics	Development and Use of Treatment Endpoints in Research and Clinical Care for Rare Disorders	1.5
Clinical Genetics and Therapeutics	Vascular Anomalies with and without Overgrowth: Mechanisms of Disease, Diagnosis, Modeling and Treatment	1.5
Clinical Genetics and Therapeutics	Challenges in Interdisciplinary Testing for Monogenic Causes of Diseases: Case Examples in Kidney Disease	1.5
Clinical Genetics and Therapeutics	Genetics in Art: Cultures Across Centuries Which Teach Us Dysmorphology and Humanity	1.5
Clinical Genetics and Therapeutics	Genetic Counselors Forum: What’s in a Title? The Road to Faculty Appointments for Genetic Counselors and Titles in Other Settings	1.5
Clinical Genetics and Therapeutics	Cardinal Signs	1.5
Clinical Genetics and Therapeutics	Back to Basics: The Physical Exam is the Cornerstone of Precision Medicine	1.5
Health Services and Implementation	The Path to Evidence-Based Guidelines	1.5
Health Services and Implementation	R. Rodney Howell Symposium \| Setting the Stage for Genomic Sequencing of All Newborns	1.5
Health Services and Implementation	2023 ACMG Awards and Presidential Plenary Session - OK, We’re All Sequenced. Now What?	1.5
Laboratory Genetics and Genomics	Innovations in Genomic Diagnostics	1.5
Laboratory Genetics and Genomics	Accelerating Variant Interpretation in Cancer Susceptibility Genes	1.5
Prenatal Genetics	Prenatal to the Cradle: The Journey of Genetic Testing During Pregnancy	1.5
Prenatal Genetics	Debates in Reproductive Genetics	1.5
Research Methods & Resources	How to Use the Human Pangenome Reference in AnVIL	1.5
SELI, Public Health and Policy	Ethical Issues in Genomic Science Dissemination: Perspectives from Genetics in Medicine	1.5
SELI, Public Health and Policy	Obligations to Patients, Families and Populations When Sharing Genomic Information – A SELI-sponsored Session	1.5
SELI, Public Health and Policy	Bringing the World Together to Improve Access to Genomic Medicine: Lessons from Serving Consanguineous and Founder Populations	1.5
SELI, Public Health and Policy	Frameshifting Our Inadequacy Gene	1.5
SELI, Public Health and Policy	Is Personalized Medicine Part of the Problem or the Solution to Healthcare Access and Equity? Charting a Course for Genomics to Lead The Way	1.5
SELI, Public Health and Policy	How to Turn ‘Minority Tax' Into 'Minority Capital' and Build an Academic Career Based on DEI Work	1.5
SELI, Public Health and Policy	The Intersection of Reproductive Autonomy and Disability Rights	1.5
Total Credits		46.5

Continuing Medical Education (CME AMA & CME Other)

Accreditation
The American College of Medical Genetics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 46.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

P.A.C.E.^®CEU's
ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program.

ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). This course is registered with CEBroker # 20-1025480. ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.® (275-200-23). This activity has been approved for 46.5 P.A.C.E.® CEU's.

National Society of Genetic Counselors (NSGC)

The National Society of Genetic Counselors (NSGC) has authorized American College of Medical Genetics and Genomics (ACMG) to offer up to 4.65 CEUs or 46.50 Category 1 contact hours for the activity 2023 ACMG Annual Clinical Genetics Meeting Digital Edition. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

ACMG reports completed accredited sessions to NSGC for credit certificates annually.

Reporting year	Participant deadline to claim credits	ACMG reporting date
2023	12/4/2023	12/6/2023
2024	12/2/2024	12/4/2024
2025	3/31/2025	5/30/2025

Participation Instructions (OnDemand)

Complete session by watching recordings.
Pass a post-test with a score of 80% or better (Learning mode activated and reset available).
Complete session evaluations.

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

All relevant financial relationships listed have been mitigated.

Name	Role: Presenter/Panelist/Moderator/ Liaison/Program Committee Member/Peer Reviewer	Financial Disclosure Relationship/Company
Abraham, Roshini	CE Presenter	Scientific Medical Advisor relationship with Enzyvant; Has ended; Speaker/ Speaker's Bureau relationship with Beckman Coulter; Has ended
Abu-El-Haija, Aya	Moderator	No Relevant Financial Relationships
Adams, Denise	CE Presenter	Consultant relationship with Novartis; Has not ended; Consultant relationship with Venthera; Has not ended
Aksentijevich, Ivona	CE Presenter	No Relevant Financial Relationships
Al-Kouatly, Huda	CE Presenter	No Relevant Financial Relationships
Alkuraya, Fowzan	CE Presenter	Scientific Medical Advisor relationship with Neutrolis; Has not ended
Amudhavalli, Shivarajan	Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Arian, Sara	CE Presenter	No Relevant Financial Relationships
Astiazaran Symonds, Esteban	Moderator	No Relevant Financial Relationships
Babcock, Holly	CE Presenter	No Relevant Financial Relationships
Bacino, Carlos	Platform Presenter	Institutional Research for Clinical Trials: BioMarin Pharmaceutical
Barnett, Claudia	Program Committee Member	No Relevant Financial Relationships
Bekheirnia, Mir Reza	CE Presenter	No Relevant Financial Relationships
Bennett, James	CE Presenter	No Relevant Financial Relationships
Bernat, John	Liaison/Program Committee Member	Research support for clinical trials: Avrobio, BioMarin Pharmaceutical Inc., Chiesi USA Inc, Idorsia Pharmaceuticals, Pfizer, Inc., Protalix Biotherapeutics, Sangamo Therapeutics, Sanofi, Takeda Pharmaceutical, Travere Therapeutics, Inc.
Berry, Susan	CE Presenter/Liaison/Program Committee Member	DSMB Member relationship with Sanofi; Has not ended; Clinical Trial Site PI relationship with Hemoshear; Has not ended; Clinical Trial Site PI relationship with Arturus; Has not ended
Besser, Andria	CE Presenter	No Relevant Financial Relationships
Binford, Warren	CE Presenter	No Relevant Financial Relationships
Bird, Lynne	Moderator	No Relevant Financial Relationships
Boothe, Emily	Platform Presenter	No Relevant Financial Relationships
Botto, Lorenzo	CE Presenter	PI of a patient natural history registry relationship with Alexion; Has not ended
Brewer, Casey	Moderator	No Relevant Financial Relationships
Brothers, Kyle	CE Presenter	Research funding from Invitae; Has not ended
Brower, Amy	Moderator	No Relevant Financial Relationships
Brunelli, Luca	CE Presenter	No Relevant Financial Relationships
Burger, Pauline	Platform Presenter	No Relevant Financial Relationships
Carter, Lauren	Liaison/Peer Reviewer	No Relevant Financial Relationships
Cassiman, David	CE Presenter	Consultant relationship with Sanofi; Has not ended; Speaker/ Speaker's Bureau relationship with Alnylam; Has not ended; Speaker/ Speaker's Bureau relationship with Orphalan; Has not ended; Speaker/ Speaker's Bureau relationship with Takeda; Has not ended
Cho, Mildred	CE Presenter	No Relevant Financial Relationships
Choi, Sarah	Platform Presenter	No Relevant Financial Relationships
Chung, Wendy	CE Presenter	Scientific Medical Advisor relationship with Regeneron Genetic Center; Has not ended; Individual stocks and stock options relationship with Prime Medicine; Has not ended; Individual stocks and stock options relationship with Rallybio; Has not ended
Cline, Melissa	CE Presenter	No Relevant Financial Relationships
Conboy, Erin	Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Cooperstein, Isabelle	Platform Presenter	No Relevant Financial Relationships
Cottrell, Catherine	CE Presenter	No Relevant Financial Relationships
Cragun, Deborah	CE Presenter	No Relevant Financial Relationships
Craig, David	CE Presenter	No Relevant Financial Relationships
Dahlroth, Jane	Program Committee Member	No Relevant Financial Relationships
Demmer, Laurie	Moderator	No Relevant Financial Relationships
Dixon, J. Brandon	CE Presenter	Owner/Founder relationship with LymphaTech; Has not ended
Duque Lasio, Maria Laura	Moderator	No Relevant Financial Relationships
Duyzend, Michael	Platform Presenter	No Relevant Financial Relationships
Eddleman, Keith	Liaison/Program Committee Member	No Relevant Financial Relationships
Elias, Abdallah	Platform Presenter	Consultant relationship with Illumina; Has not ended
Elsea, Sarah	Liaison/Program Committee Member	No Relevant Financial Relationships
Erez, Ayelet	CE Presenter	No Relevant Financial Relationships
Ferreira, Carlos	CE Presenter	Research funding from ineligible companies relationship with Inozyme Pharma; Has not ended
Fishbein, Lauren	CE Presenter	Consultant relationship with Lantheus/Progenics; Has not ended
Francis, Leslie	CE Presenter	No Relevant Financial Relationships
Freire, Penelope	Program Committee Member	No Relevant Financial Relationships
Gambello, Michael	Moderator/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Ganetzky, Rebecca	CE Presenter	Consultant relationship with Minovia Therapeutics; Has not ended; Consultant relationship with Nurture Genomics; Has not ended
Gerald, Dayebgadoh	Platform Presenter	No Relevant Financial Relationships
Ghosh, Rajarshi	Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Giordano, Jessica	Moderator	No Relevant Financial Relationships
Gold, Nina	Contributor	Consultant relationship with RCG Consulting, LLC; Has not ended
Gripp, Karen W.	CE Presenter	No Relevant Financial Relationships
Groopman, Emily	Platform Presenter	No Relevant Financial Relationships
Gropman, Andrea	CE Presenter	No Relevant Financial Relationships
Hannibal, Mark	CE Presenter	No Relevant Financial Relationships
Haque, Bushra	Platform Presenter	No Relevant Financial Relationships
Hayek, Jennifer	Platform Presenter	No Relevant Financial Relationships
Higgins, Jan	CE Presenter	No Relevant Financial Relationships
Hoffman, Jodi	Moderator/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Hofler, Lisa	CE Presenter	No Relevant Financial Relationships
Hoover-Fong, Julie	CE Presenter	Consultant relationship with Biomarin; Has not ended; Researcher relationship with Biomarin; Has not ended; Researcher relationship with Pfizer; Has not ended; Consultant relationship with QED Therapeutics; Has not ended; Researcher relationship with QED Therapeutics; Has not ended
Hoskovec, Jennifer	CE Presenter	Employee relationship with BillionToOne Inc.; Has not ended; Individual stocks and stock options relationship with BillionToOne Inc.; Has not ended
Hurst, Anna	Moderator	Consultant relationship with CFD Research; Has not ended
Iacobas, Ionela	CE Presenter	No Relevant Financial Relationships
Iltis, Ana	CE Presenter	No Relevant Financial Relationships
Jenkins, Gabrielle	CE Presenter	No Relevant Financial Relationships
Jurgensmeyer, Sarah	Platform Presenter	No Relevant Financial Relationships
Kalish, Jennifer	CE Presenter	No Relevant Financial Relationships
Kantaputra, Piranit	CE Presenter	No Relevant Financial Relationships
Kaphingst, Kimberly	CE Presenter	No Relevant Financial Relationships
Kaur, Shagun	CE Presenter	No Relevant Financial Relationships
Khushf, George	Moderator	No Relevant Financial Relationships
King, Jennifer	Moderator/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Kingsmore, Stephen	Moderator	Researcher relationship with Takeda; Has not ended; Researcher relationship with Alexion; Has not ended; Researcher relationship with Travere; Has not ended; Researcher relationship with Inozyme; Has not ended; Researcher relationship with Ultragenyx; Has not ended; Researcher relationship with Sarepta; Has not ended; Researcher relationship with Horizon; Has not ended; Researcher relationship with Illumina; Has not ended; Speaker/ Speaker's Bureau relationship with Illumina; Has ended; Researcher relationship with Sentynl; Has not ended; Researcher relationship with Mahzi; Has not ended; Researcher relationship with Orchard; Has not ended
Kirmani, Salman	CE Presenter	No Relevant Financial Relationships
Koch, Rebecca	Platform Presenter	No Relevant Financial Relationships
Kolhe, Ravindra	CE Presenter	Researcher relationship with Illumina; Has not ended; Scientific Medical Advisor relationship with Agena; Has not ended; Scientific Medical Advisor relationship with Qiagen; Has not ended; Researcher relationship with Perkin Elmer; Has not ended; Researcher relationship with Bionano; Has not ended; Speaker/ Speaker's Bureau relationship with PGDx; Has not ended; Consultant relationship with Ceppheid; Has ended; Scientific Medical Advisor relationship with AbbVie; Has ended
Kolla, Kavitha	CE Presenter	No Relevant Financial Relationships
Kopp, Nathan	Moderator/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Korson, Mark	CE Presenter	Research funding from ineligible companies relationship with Recordati Rare Diseases; Has not ended; Research funding from ineligible companies relationship with Aeglea Biotherapeutics; Has not ended; Research funding from ineligible companies relationship with Travere Therapeutics; Has not ended; Consultant relationship with HemoShear Therapeutics; Has not ended; Consultant relationship with Glycomine; Has not ended; Consultant relationship with Solace Nutrition; Has not ended; Consultant relationship with Eton Pharmaceuticals; Has not ended; Consultant relationship with Tessera Therapeutics; Has ended
Kulchak Rahm, Alanna	Moderator/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Lam, Christina	CE Presenter	Consultant relationship with Maggie's Pearl L.L.C; Has not ended; Independent contractor (including contracted research) relationship with Glycomine, Inc.; Has not ended
Landrum, Melissa	Platform Presenter	No Relevant Financial Relationships
Lebo, Matthew	CE Presenter/Platform Presenter	No Relevant Financial Relationships
Lee, Whiwon	Platform Presenter	No Relevant Financial Relationships
Lemaire, Mathieu	CE Presenter	No Relevant Financial Relationships
Lertwilaiwittaya, Pongtawat	Platform Presenter	No Relevant Financial Relationships
Lesmana, Harry	CE Presenter	No Relevant Financial Relationships
Li, Hong	Moderator	Independent contractor (including contracted research) relationship with Logicbio; Has not ended; Independent contractor (including contracted research) relationship with Travere; Has not ended; Independent contractor (including contracted research) relationship with homology; Has ended; Scientific Medical Advisor relationship with Ultragenyx; Has ended; Consultant relationship with Acer therapeutics; Has ended; Independent contractor (including contracted research) relationship with Moderna; Has ended
Lin, Angela	CE Presenter	No Relevant Financial Relationships
Lucas, Julian	CE Presenter	Independent contractor (including contracted research) relationship with Prime Genomics; Has ended
Lyon, Megan	Platform Presenter	No Relevant Financial Relationships
Maher, Louis	CE Presenter	No Relevant Financial Relationships
Mamidi, Tarun Karthik Kumar	Platform Presenter	No Relevant Financial Relationships
Manickam, Kandamurugu	CE Presenter	No Relevant Financial Relationships
Manolio, Teri	Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Matern, Dietrich	CE Presenter	Scientific Medical Advisor relationship with Neurogene; Has ended
Mehta, Lakshmi	Moderator	No Relevant Financial Relationships
Merchant, Nadia	CE Presenter	Scientific Medical Advisor relationship with BioMarin; Has not ended; Scientific Medical Advisor relationship with Pfizer; Has not ended
Militante, Julius	Platform Presenter	No Relevant Financial Relationships
Mito, Yoshiko	Moderator/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Mohan, Shruthi	Platform Presenter	No Relevant Financial Relationships
Monlong, Jean	CE Presenter	No Relevant Financial Relationships
Mori, Mari	Moderator	UltraGenyx Medical Affairs LCFAOD Advisory Board relationship with Ultragenyx; Has not ended
Moscicki, Richard	CE Presenter	Executive role relationship with PhRMA; Has ended; Board Directgor relationship with LogicBio Therapeutics; Has ended
Murali, Chaya	CE Presenter	Research funding from ineligible companies relationship with Biomarin; Has not ended
Muschol, Nicole	Platform Presenter	Speaker/ Speaker's Bureau relationship with Chiesi; Has not ended; Scientific Medical Advisor relationship with Chiesi; Has ended; Speaker/ Speaker's Bureau relationship with Sanofi; Has ended; Scientific Medical Advisor relationship with Sanofi; Has ended; Speaker/ Speaker's Bureau relationship with Takeda; Has ended; Scientific Medical Advisor relationship with Takeda; Has ended; Scientific Medical Advisor relationship with JCR; Has ended; Speaker/ Speaker's Bureau relationship with amicus; Has ended; Scientific Medical Advisor relationship with Amicus; Has ended; Speaker/ Speaker's Bureau relationship with Biomarin; Has ended; Scientific Medical Advisor relationship with Biomarin; Has ended
Narumanchi, TaraChandra	Moderator	Scientific Medical Advisor relationship with River West Meeting Associates; Has ended
Nathanson, Katherine	CE Presenter	No Relevant Financial Relationships
Netto, Alice Brinckmann Oliveira	Platform Presenter	No Relevant Financial Relationships
Niehaus, Annie	Liaison, Peer Reviewer	No Relevant Financial Relationships
Null, Elizabeth	CE Presenter	No Relevant Financial Relationships
Olson, Rory	Platform Presenter	No Relevant Financial Relationships
Paine, Taunton	CE Presenter	No Relevant Financial Relationships
Pal, Tuya	CE Presenter	Scientific Medical Advisor relationship with Natera; Has not ended
Parvin, Jeffrey	CE Presenter	No Relevant Financial Relationships
Paschal, Cate	Platform Presenter	No Relevant Financial Relationships
Pasquali, Marzia	CE Presenter	Consultant relationship with Horizon Therapeutics, USA; Has ended; Consultant relationship with Recordati Rare Diseases; Has not ended; Consultant relationship with Takeda; Has not ended
Patel, Neil	CE Presenter	No Relevant Financial Relationships
Paul Daniel, Earnest James	Platform Presenter	No Relevant Financial Relationships
Pena, Loren	Moderator	Consultant relationship with CVS Caremark; Has ended
Peterson, Josh	CE Presenter	Scientific Medical Advisor relationship with Natera; Has not ended
Plon, Sharon	CE Presenter	No Relevant Financial Relationships
Popejoy, Alice	Moderator	No Relevant Financial Relationships
Pori, Isabella	CE Presenter	No Relevant Financial Relationships
Powell, Cynthia	CE Presenter	No Relevant Financial Relationships
Pronman, Lauren	Liaison, Peer Reviewer	No Relevant Financial Relationships
Pyle, Louise	CE Presenter	No Relevant Financial Relationships
Quintero-Rivera, Fabiola	Platform Presenter	No Relevant Financial Relationships
Radford, Jane	Program Committee Member	No Relevant Financial Relationships
Radivojac, Predrag	CE Presenter	Consultant relationship with BioMarin; Has not ended
Reddi, Honey	CE Presenter	Consultant relationship with Biofidelity Inc; Has not ended; Employee relationship with Medical College of Wisconsin; Has not ended
Regier, Debra	Moderator	No Relevant Financial Relationships
Rehm, Heidi	CE Presenter	Scientific Medical Advisor relationship with Genome Medical, Inc.; Has not ended
Richardson, Marcy	CE Presenter	Employee relationship with Ambry Genetics; Has not ended
Ritter, Deborah	Platform Presenter	No Relevant Financial Relationships
Roberts, Mary-Beth	CE Presenter	No Relevant Financial Relationships
Rohrwasser, Andreas	CE Presenter	No Relevant Financial Relationships
Rowsey, Ross	Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Saal, Howard	CE Presenter	Speaker/ Speaker's Bureau relationship with Alexion Pharmaceuticals; Has not ended
Sadikovic, Bekim	CE Presenter	No Relevant Financial Relationships
Sanchez Russo, Rossana	Moderator	Consultant relationship with Perkin Elmer; Has ended
Sanchez, John	CE Presenter	No Relevant Financial Relationships
Sanchez, Pedro	CE Presenter	No Relevant Financial Relationships
Santoro, Stephanie	CE Presenter	No Relevant Financial Relationships
Sas, David	CE Presenter	Research funding from ineligible companies relationship with Alnylam; Has not ended; Research funding from ineligible companies relationship with Dicerna; Has not ended; Consultant relationship with Advicenee; Has not ended
Schieffer, Kathleen	Platform Presenter	No Relevant Financial Relationships
Schimmenti, Lisa	CE Presenter	No Relevant Financial Relationships
Schneider, Kami	CE Presenter	No Relevant Financial Relationships
Schrader, Kasmintan	Platform Presenter	Consultant relationship with AstraZeneca Canada; Has ended; Consultant relationship with Precision RxDx; Has ended
Scott, Stuart	Moderator	No Relevant Financial Relationships
Shaaban, Sherin	Moderator	Consultant relationship with Fabric Genomics; Has ended
Shah, Anamika	Platform Presenter	No Relevant Financial Relationships
Sheppard, Sarah	CE Presenter	No Relevant Financial Relationships
Shi, Xinrui	Platform Presenter	No Relevant Financial Relationships
Shillington, Amelle	Platform Presenter	Speaker/ Speaker's Bureau relationship with PreventionGenetics; Has ended; Consultant relationship with Illumina; Has not ended
Siddharth, Aishwarya	Platform Presenter	Speaker/ Speaker's Bureau relationship with Sio Gene; Has ended; Consultant relationship with Amicus; Has not ended
Singer, Tyler	Platform Presenter	No Relevant Financial Relationships
Smith, Hadley	Platform Presenter	Consultant relationship with Illumina, Inc.; Has ended
Sobreira, Nara	CE Presenter	No Relevant Financial Relationships
Sparks, Teresa	Platform Presenter	Content expert for one-time meeting about hydrops fetalis relationship with Ultragenyx; Has ended
Steiner, Robert	Moderator	Employee relationship with PreventionGenetics; Has not ended; stock and consultant relationship with Acer Therapeutics; Has not ended; Consultant relationship with Travere; Has not ended; Consultant relationship with PTC Therapeutics; Has not ended; Consultant relationship with Leadiant; Has not ended; Individual stocks and stock options relationship with PTC Therapeutics; Has not ended; Research funding from ineligible companies relationship with Alexion; Has not ended
Stewart, Douglas	CE Presenter/Platform Presenter	No Relevant Financial Relationships
Stover, Samantha	CE Presenter/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Stramondo, Joseph	CE Presenter	No Relevant Financial Relationships
Strauss, Kevin	CE Presenter	Research funding from ineligible companies relationship with Novartis Gene Therapies; Has ended; Research funding from ineligible companies relationship with ASC Therapeutics; Has not ended
Sutherland, Nykole	Platform Presenter	No Relevant Financial Relationships
Tabery, James	CE Presenter	No Relevant Financial Relationships
Tan, Wen-Hann	Platform Presenter	Independent contractor (including contracted research) relationship with Ionis Pharmaceuticals; Has not ended; Independent contractor (including contracted research) relationship with F. Hoffman-La Roche; Has ended; Independent contractor (including contracted research) relationship with Ultragenyx; Has not ended; Independent contractor (including contracted research) relationship with Casimir LLC; Has not ended; Independent contractor (including contracted research) relationship with Biogen; Has ended; Data Monitoring Committee member relationship with Takeda Pharmaceutical Company; Has not ended; Consultant relationship with Denali Therapeutics; Has not ended; Independent contractor (including contracted research) relationship with Ovid Therapeutics; Has ended
Tartaglia, Nicole	Platform Presenter	Independent contractor (including contracted research) relationship with Tetra Pharmaceuticals; Has not ended; Independent contractor (including contracted research) relationship with Zynerba Pharmaceuticals; Has not ended
Tavtigian, Sean	Moderator	No Relevant Financial Relationships
Thomas, Christie	CE Presenter	No Relevant Financial Relationships
Thompson, Katarzyna	Moderator/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Tinker, Rory	Platform Presenter	No Relevant Financial Relationships
Tischkowitz, Marc	Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Tolusso, Leandra	CE Presenter	No Relevant Financial Relationships
Torgerson, Troy	CE Presenter	Scientific Medical Advisor relationship with Takeda pharmaceuticals; Has ended; Scientific Medical Advisor relationship with CSL Behring; Has ended; Scientific Medical Advisor relationship with Grifols; Has ended; Scientific Medical Advisor relationship with Horizon Pharmaceuticals; Has ended; Scientific Medical Advisor relationship with X4 Pharmaceuticals; Has ended; Scientific Medical Advisor relationship with Pharming Healthcare; Has not ended
Tsosie, Krystal	CE Presenter	Speaker's Bureau relationship with Regeneron; Has ended
Turley, Patrick	CE Presenter	No Relevant Financial Relationships
Uhlmann, Wendy	CE Presenter	No Relevant Financial Relationships
Van Ziffle, Jessica	CE Presenter	No Relevant Financial Relationships
Varga, Elizabeth	Moderator	No Relevant Financial Relationships
Vernon, Hilary	Platform Presenter	Clinical trial and research support relationship with stealth biotherapeutics; Has not ended; Clinical trial support relationship with moderna; Has not ended; Clinical trial support relationship with PTC therapeutcs; Has not ended
Verscaj, Courtney	Platform Presenter	No Relevant Financial Relationships
Vockley, Jerry	CE Presenter	Consultant relationship with AroBioTx; Has ended; Consultant relationship with Acer; Has ended; Consultant relationship with Satellite Bio; Has ended; Consultant relationship with Horizon Therapeutics; Has ended; Consultant relationship with Illumina Inc; Has ended; Consultant relationship with BioMarin Pharmaceutical Inc.; Has ended; Consultant relationship with LogicBio Pharmaceuticals; Has ended; Consultant relationship with Sangamo Therapeutics Inc.; Has ended; Consultant relationship with Orphan Labs; Has ended; Consultant relationship with Synlogic; Has ended; Individual stocks and stock options relationship with American Gene Technologies International Inc.; Has not ended; Consultant relationship with American Gene Technologies International Inc.; Has ended; Consultant relationship with Sanofi; Has ended; Consultant relationship with Axcella Health; Has ended; Individual stocks and stock options relationship with Axcella Health; Has not ended; Consultant relationship with Agios Pharmaceuticals; Has ended; Consultant relationship with Applied Therapeutics; Has ended; Consultant relationship with Moderna Pharmaceuticals; Has ended; Consultant relationship with JNATX; Has not ended; Research funding from ineligible companies relationship with Kriya Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with Ultragenyx Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with Aeglea Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with Reneo Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with PTC Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with Horizon Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with Synlogic Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with Biomarin Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with Arcturus Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with CoA Therapeutics; Has not ended; Research funding from ineligible companies relationship with Hemoshear Pharmaceuticals; Has not ended; Research funding from ineligible companies relationship with Nestle Life Sciences; Has not ended; Research funding from ineligible companies relationship with Stealth Therapeutics; Has not ended
Vogel, Tiphanie	CE Presenter	Consultant relationship with SOBI; Has ended; Consultant relationship with Novartis; Has ended; Consultant relationship with Pfizer; Has ended; Consultant relationship with Moderna; Has not ended
Vossaert, Liesbeth	CE Presenter	No Relevant Financial Relationships
Wand, Hannah	CE Presenter	No Relevant Financial Relationships
Wang, Kai	CE Presenter	No Relevant Financial Relationships
Wang, Xiangling	CE Presenter	Consultant relationship with Alnylam Pharmaceuticals; Has ended; Consultant relationship with Alnylam Pharmaceuticals; Has ended; Scientific Medical Advisor relationship with Natera; Has not ended; Scientific Medical Advisor relationship with Sanofi/Genezyme; Has not ended
Wechsler, Stephanie	CE Presenter	No Relevant Financial Relationships
Westerfield, Lauren	CE Presenter	No Relevant Financial Relationships
Wexler, Anna	CE Presenter	No Relevant Financial Relationships
Whelan, Colleen	Program Committee Member	No Relevant Financial Relationships
Wick, Myra	Moderator/Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Wiesner, Georgia	CE Presenter	No Relevant Financial Relationships
Williams, Marc	CE Presenter/Liaison/Program Committee Member	No Relevant Financial Relationships
Wilson, Kirkland	Moderator	No Relevant Financial Relationships
Wise, David	Platform Presenter	Consultant relationship with Leap Therapeutics; Has not ended; Consultant relationship with Pfizer; Has not ended; Consultant relationship with Janssen; Has not ended; Consultant relationship with Labcorp; Has ended; Consultant relationship with Myovant; Has ended; Consultant relationship with Lilly; Has not ended; Consultant relationship with Bayer; Has not ended; Consultant relationship with Sanofi; Has ended
Wright, Carter	Platform Presenter	No Relevant Financial Relationships
Young, Sarah	CE Presenter	Consultant relationship with Amicus Therapeutics; Has ended; Research funding from ineligible companies relationship with Maze Therapeutics; Has not ended; Research funding from ineligible companies relationship with Aro Biotherapeutics; Has not ended
Yuen, Amy	CE Presenter	No Relevant Financial Relationships
Zawati, Ma'n	CE Presenter	No Relevant Financial Relationships
Zepeda Mendoza, Cinthya	Liaison/Program Committee Member/Peer Reviewer	No Relevant Financial Relationships
Zhang, Jinglan	Platform Presenter	Owner/Founder relationship with BioBiggen Llc; Has not ended; Owner/Founder relationship with Heristar Llc; Has not ended